ESTRO 35 2016 S771 ________________________________________________________________________________ circumference of the vessel). The vascular PTV (PTVv) was considered as the CTVv plus an anisotropic margin (5 mm CC, 3 mm in other directions). The tumor PTV (PTVt) was defined as the GTV plus an anisotropic margin (5 mm CC, 3 mm in other directions) including the PTVv and excluding the PTVd. The following doses were prescribed [in 5 daily fractions (fr)] to the PTVs: 30 Gy (6 Gy/fr) to the PTVd, 45 Gy (9 Gy/fr) to the PTVv, and 37.5 Gy (7.5 Gy/fr) to the PTVt, respectively. Constraints were based on AAPM TG101 recommendations: Dmax of PRVduodenum < 32.0 Gy, Dmax of PRVspinal cord < 30.0 Gy, Dmax of PRVstomach < 32.0%, D700cc liver < 21.0 Gy, D200 cc kidneys < 17.5 Gy. All plans were generated with Masterplan Oncentra TPS and the treatment was delivered with a step and shot IMRT technique. The primary end point was the rate of patients in whom the constraint Dmean > 90% was achieved for the 3 different PTVs. Secondary end points were the percentage of patients in whom a PTVv near minimum dose (D98%) > 90%, a PTVv D95% > 95%, and a median dose (D50%) > 95% were achieved.
Results: PTVv Dmean > 90%, PTVv D2% < 115% and OARs Dmax constraints were achieved in all patients. Both PTVv D98% > 90% and PTVv D95% > 95% were achieved in 6 patients (40%).
Conclusion:
Although the objective of PTVv D95% > 95% was achieved only in 40% of patients, the study showed that in 100% of patients it was possible to administer a strongly differentiated mean and median dose, and in particular a low dose to the overlap region between the target and duodenum, a high dose to the site of vascular infiltration, and an intermediate dose to the remaining target volume. Prospective trials based on clinical application of this strategy seems to be justified at least in selected patients. Purpose or Objective: Whole breast irradiation is part of breast conservative management for early breast cancer. In addition to that boost dose to tumor bed improves local recurrence rates and is currently the standard of care. Our aim of the current study was to evaluate intensity modulated radiation therapy (IMRT) for whole breast versus its dosimetric properties of volumetric modulated arc therapy (VMAT).
EP-

Material and Methods:
Eighteen consecutive women with left sided breast cancer were taken for this retrospective study. IMRT treatment plans were created for patients who already received treatment with VMAT. The plans were created in Monaco planning system using Monte Carlo (MC) algorithm. The Elekta Infinity linear accelerator with Agility MLC is used for VMAT delivery. Our clinic uses simultaneous integrated boost (SIB) technique to treat whole breast patients. The dose prescribed was 60Gy/25# to tumor bed and 45Gy/25# for whole breast. The plans were evaluated based on QUANTTEC dose-volume protocol. Data were statistically analyzed using Wilcoxon Signed Rank test.
Results:
VMAT technique statistically significant in target coverage and dose conformity than IMRT. In addition to that lesser ipsilateral & contra lateral lung dose and reduced contra lateral breast dose with VMAT. Critical structures like Left descending artery(LAD), Spinal Cord and heart also received lower doses with VMAT than IMRT . All the dosimetric parameters and its statistical values were provided in table1.Statistics shows VMAT more significant for LAD, Ipsilateral lung dose and Conformity Index.
Conclusion:
From this study , we infer that, our switch over from IMRT to VMAT treatment technique provided better dosimetric effect for left sided breast cancer patients. Also VMAT provided significant improvement target coverage and conformity. It reduced the dose to normal tissues further to IMRT.
EP-1651
Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality S.H. Son 
Material and Methods:
Twenty patients with unresectable HCC treated with tomotherapy were selected. We performed tomotherapy re-planning to reduce the non-target normal liver volume receiving a dose of more than 15 Gy (NTNLV15Gy), and we created a fixed-beam IMRT plan (FB-P). We compared the dosimetric results as well as the estimated probability of RIHT among the tomotherapy initial plan (T-IP), the tomotherapy re-plan (T-RP), and the FB-P.
Results: Comparing the T-RP and FB-P, the homogeneity index was 0.11 better with the T-RP. However, the mean NTNL-V15Gy was 6.3% lower with the FB-P. These differences result in a decline in the probability of RIHT from 0.216 in the T-RP to 0.115 in the FB-P. In patients whose NTNL-V15Gy was higher than 43.2% with the T-RP, the probability of RIHT markedly reduced from 0.533 to 0.274.
